Amin Taha Turki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amin Taha Turki has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alma Aslan
Agaplesion Bethesda Ulm, Geriatric Centre Ulm/Alb-Donau, Ulm, Germany, Germany
1 shared publication - Chantal Giehl
Department of Geriatric Medicine, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany
1 shared publication - Christian Baues
Department of Radiation Oncology, Marien Hospital Herne, University Hospital, Ruhr University Bochum, Herne, Germany, Germany
1 shared publication - Dennis Akuamoa-Boateng
Department of Radiation Oncology, Marien Hospital Herne, University Hospital, Ruhr University Bochum, Herne, Germany, Germany
1 shared publication - Dirk Strumberg
Department of Hematology and Oncology, Marien Hospital Herne, University Hospital, Ruhr University Bochum, Herne, Germany, Germany
1 shared publication - Filippo Maria Verri
Institute for Geriatric Research at Agaplesion Bethesda Ulm, Ulm University Medical Center, Ulm, Germany
1 shared publication
Latest Publications
- Open Access
- 7 January 2026
- Published by MDPI AG in Preprints.org
Integration of Geriatric Assessment—Guided Care Plan Modifications and Interventions into Clinical Paths of Older Adults with Cancer (GORILLA): A Feasibility Approach
Background/Objectives: A comprehensive geriatric assessment (CGA) was demon-strated to reduce treatment-related toxicities CTCAE III-V° in older adults with cancer undergoing systemic cancer treatments. However, practical implementation of this important procedure is insufficient. To evaluate the feasibility of implementing CGA into routine care and multidisciplinary tumor boards (MDTs) in Germany, we per-formed this bicentric feasibility trial. Methods: Patients ≥65 years with positive geriatric screening (G8< 15 points) and all patients ≥70 years received CGA as part of their routine care. Results were presented during MDT discussions to derive treatment recommendations. After CGA, patients were asked for trial participation which included data analysis and a telephone fol-low-up after 3 months. Physicians participating in the MDT were asked about the added value of CGA presentation. Primary endpoint was the estimation of patient’s willing-ness to participate with an accuracy of ± 7.5% to inform design for a later effectiveness trial. Results: 75 patients received CGA. Of those, 72 (96%) agreed to participate (95% confi-dence interval, [0.8875; 0.9917]). With an accuracy of estimating the willingness to par-ticipate of < |7.5%|, the primary endpoint was reached. The median age was 76.6 years (range: 69-92 years). A member of the geriatric team attended 2/3 of the MDT meetings. Physicians rated the integration of CGA results predominantly as useful. Conclusions: Integration of CGA into routine care of older cancer patients is feasible but will likely require adequate geriatric staffing per center. A larger implementation study, evaluating efficacy and cost effectiveness in the German healthcare system, is necessary.
- 7 January 2026
- Published by MDPI AG in Preprints.org
Open AccessIntegration of Geriatric Assessment—Guided Care Plan Modifications and Interventions into Clinical Paths of Older Adults with Cancer (GORILLA): A Feasibility Approach
Background/Objectives: A comprehensive geriatric assessment (CGA) was demon-strated to reduce treatment-related toxicities CTCAE III-V° in older adults with cancer undergoing systemic cancer treatments. However, practical implementation of this important procedure is insufficient. To evaluate the feasibility of implementing CGA into routine care and multidisciplinary tumor boards (MDTs) in Germany, we per-formed this bicentric feasibility trial. Methods: Patients ≥65 years with positive geriatric screening (G8< 15 points) and all patients ≥70 years received CGA as part of their routine care. Results were presented during MDT discussions to derive treatment recommendations. After CGA, patients were asked for trial participation which included data analysis and a telephone fol-low-up after 3 months. Physicians participating in the MDT were asked about the added value of CGA presentation. Primary endpoint was the estimation of patient’s willing-ness to participate with an accuracy of ± 7.5% to inform design for a later effectiveness trial. Results: 75 patients received CGA. Of those, 72 (96%) agreed to participate (95% confi-dence interval, [0.8875; 0.9917]). With an accuracy of estimating the willingness to par-ticipate of < |7.5%|, the primary endpoint was reached. The median age was 76.6 years (range: 69-92 years). A member of the geriatric team attended 2/3 of the MDT meetings. Physicians rated the integration of CGA results predominantly as useful. Conclusions: Integration of CGA into routine care of older cancer patients is feasible but will likely require adequate geriatric staffing per center. A larger implementation study, evaluating efficacy and cost effectiveness in the German healthcare system, is necessary.